Literature DB >> 24485335

TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer.

Yukiko Kanno1, Masashi Watanabe2, Taichi Kimura3, Katsuya Nonomura4, Shinya Tanaka3, Shigetsugu Hatakeyama5.   

Abstract

Tripartite motif protein 29 (TRIM29) is one of the TRIM family proteins, some of which function as E3 ubiquitin ligases. In this study, we investigated the usefulness of TRIM29 for diagnosis of prostate cancer. Prostate tissues including carcinoma and non-carcinoma tissues obtained by needle biopsy and radical prostatectomy were used. Immunohistochemistry was performed according to standard procedures using an antibody against TRIM29. Immunohistochemical staining with an antibody against 34βE12, which recognizes cytokeratins 1, 5, 10 and 14, was performed as a control. Basal cells of normal prostatic glands were stained with anti-TRIM29 antibody in all cases, whereas prostate cancer tissues had no or little staining with anti-TRIM29 antibody. TRIM29 is selectively expressed in basal cells of the normal prostate gland, and immunohistochemical staining with anti-TRIM29 antibody showed the same expression pattern as that with 34βE12 in prostate cancer and its benign mimics. Our data indicate that TRIM29 may be useful for distinguishing prostate cancers from benign tissues.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Basal cell; Human; Prostate cancer; TRIM29

Mesh:

Substances:

Year:  2014        PMID: 24485335     DOI: 10.1016/j.acthis.2013.12.009

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  21 in total

1.  TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.

Authors:  Yasushi Masuda; Hidehisa Takahashi; Shigeo Sato; Chieri Tomomori-Sato; Anita Saraf; Michael P Washburn; Laurence Florens; Ronald C Conaway; Joan W Conaway; Shigetsugu Hatakeyama
Journal:  Nat Commun       Date:  2015-06-22       Impact factor: 14.919

2.  Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer.

Authors:  Xiaoming Song; Chunhai Fu; Xudong Yang; Dongfeng Sun; Xianqi Zhang; Jiandong Zhang
Journal:  Oncol Lett       Date:  2015-08-19       Impact factor: 2.967

3.  Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers.

Authors:  Qianshan Ding; Du He; Ke He; Qian Zhang; Meng Tang; Jinfen Dai; Hanlin Lv; Xiaochen Wang; Guoan Xiang; Honggang Yu
Journal:  Tumour Biol       Date:  2015-06-09

4.  [TRIM21 suppresses invasion of hepatocellular carcinoma cells by promoting β-catenin ubiquitylation and degradation].

Authors:  Z Zhang; Z Zhu; H Sheng; J Sun; C Cao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

Review 5.  The TRIM proteins in cancer: from expression to emerging regulatory mechanisms.

Authors:  A Mohammadi; M S Pour Abbasi; S Khorrami; S Khodamoradi; Z Mohammadi Goldar; F Ebrahimzadeh
Journal:  Clin Transl Oncol       Date:  2021-10-13       Impact factor: 3.405

6.  TRIM36 suppresses cell growth and promotes apoptosis in human esophageal squamous cell carcinoma cells by inhibiting Wnt/β-catenin signaling pathway.

Authors:  Bin Zhao; Gaofeng Qiao; Jianhua Li; Yukun Wang; XiaoDong Li; Hua Zhang; Lu Zhang
Journal:  Hum Cell       Date:  2022-06-29       Impact factor: 4.374

7.  Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection.

Authors:  Chenghu Wang; Yi Zhou; Beibei Chen; Weiwei Yuan; Jinxi Huang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

8.  TRIM29 Negatively Regulates the Type I IFN Production in Response to RNA Virus.

Authors:  Junji Xing; Ao Zhang; Laurie J Minze; Xian Chang Li; Zhiqiang Zhang
Journal:  J Immunol       Date:  2018-05-16       Impact factor: 5.422

9.  TRIM29 as a novel biomarker in pancreatic adenocarcinoma.

Authors:  Hongli Sun; Xianwei Dai; Bing Han
Journal:  Dis Markers       Date:  2014-04-22       Impact factor: 3.434

10.  Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression.

Authors:  Sayani Mukherjee; C Sudandiradoss
Journal:  Funct Integr Genomics       Date:  2021-06-29       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.